BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11750286)

  • 1. Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis.
    Kimura M; Tatsumi KI; Tada H; Izumi Y; Kaneko A; Kato M; Masuzawa M; Ikemoto M; Yabusaki Y; Hidaka Y; Amino N
    Clin Chim Acta; 2002 Feb; 316(1-2):155-64. PubMed ID: 11750286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
    Ma Y; Gregorio G; Gäken J; Muratori L; Bianchi FB; Mieli-Vergani G; Vergani D
    J Hepatol; 1997 Jun; 26(6):1396-402. PubMed ID: 9210629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
    Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
    Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential diagnosis of hepatitis: development of new laboratory tests for autoimmune hepatitis and progress in pathophysiology].
    Amino N; Kimura M; Tanaka S; Izumi Y; Ikemoto M; Tatsumi KI; Takano T; Hidaka Y
    Rinsho Byori; 2004 Jan; 52(1):44-50. PubMed ID: 14968559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between post-partum liver dysfunction and anti-cytochrome 2D6 antibodies.
    Izumi Y; Tanaka S; Hidaka Y; Shimaoka Y; Tatsumi KI; Takano T; Kaneko A; Oku K; Amino N
    Am J Reprod Immunol; 2003 Oct; 50(4):355-62. PubMed ID: 14672341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme immunoassay for autoantibodies to human liver-type arginase and its clinical application.
    Kimura M; Tatsumi KI; Tada H; Ikemoto M; Fukuda Y; Kaneko A; Kato M; Hidaka Y; Amino N
    Clin Chem; 2000 Jan; 46(1):112-7. PubMed ID: 10620579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
    Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
    Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
    Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
    Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
    Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.
    Hintermann E; Holdener M; Bayer M; Loges S; Pfeilschifter JM; Granier C; Manns MP; Christen U
    J Autoimmun; 2011 Nov; 37(3):242-53. PubMed ID: 21795021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
    Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
    Choudhuri K; Gregorio GV; Mieli-Vergani G; Vergani D
    Hepatology; 1998 Nov; 28(5):1177-81. PubMed ID: 9794898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies and their antigens in autoimmune hepatitis.
    Bogdanos DP; Mieli-Vergani G; Vergani D
    Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-analysis of clinical features of 89 patients with autoimmune hepatitis using the revised scoring system proposed by the International Autoimmune Hepatitis Group.
    Omagari K; Masuda J; Kato Y; Nakata K; Kanematsu T; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Koga M; Yano M; Kohno S
    Intern Med; 2000 Dec; 39(12):1008-12. PubMed ID: 11197782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
    Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
    Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
    Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
    Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.
    Muratori L; Parola M; Ripalti A; Robino G; Muratori P; Bellomo G; Carini R; Lenzi M; Landini MP; Albano E; Bianchi FB
    Gut; 2000 Apr; 46(4):553-61. PubMed ID: 10716687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.